Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation.

about

Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation.

Item

http://www.wikidata.org/entity/Q45856281

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Expression of Factor IX cDNA I ...... omal Cells by Electroporation.

@en

Expression of Factor IX cDNA I ...... omal Cells by Electroporation.

@nl

type

Item

label

Expression of Factor IX cDNA I ...... omal Cells by Electroporation.

@en

Expression of Factor IX cDNA I ...... omal Cells by Electroporation.

@nl

prefLabel

Expression of Factor IX cDNA I ...... omal Cells by Electroporation.

@en

Expression of Factor IX cDNA I ...... omal Cells by Electroporation.

@nl

P1476

Expression of Factor IX cDNA I ...... romal Cells by Electroporation

@en

P2093

D R Branch

http://www.w3.org/2001/XMLSchema#string

K E Matthews

http://www.w3.org/2001/XMLSchema#string

L Fouillard

http://www.w3.org/2001/XMLSchema#string

P2860

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.

Stable expression of selectable genes introduced into human hematopoietic stem cells by electric field-mediated DNA transfer.

Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells.

Expression of human factor IX in mice after injection of genetically modified myoblasts

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.

Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B

The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.

Further evidence for the importance of an androgen response element in the factor IX promoter.

P304

347-354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.1998.11746408

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Armand Keating

Barbara Guinn

P577

1998-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27414078

http://www.w3.org/2001/XMLSchema#string

P921

electroporation